prof. dr. M.J.M. (Marc ) BontenFull Professor
- Department of Epidemiology
- Department of Medical Microbiology
- Julius Center Research Program Infectious Diseases
Marc Bonten earned his MD (1991) and PhD (“the role of colonization of the upper intestinal tract in the pathogenesis of ventilator-associated pneumonia, 1994) at the Maastricht University Medical School, the Netherlands. He registered as internist in 2000, as infectious disease specialist in 2002 and as clinical microbiologist in 2008, all at the University Medical Center Utrecht, the Netherlands. Since August 2008 he is head of the Department of Medical Microbiology and leading the research group of infectious Disease Epidemiology of the Julius Center of Health Sciences and Primary Care, both at the UMC Utrecht, where he is professor of molecular epidemiology of infectious diseases since 2002. He has been a principal investigator in many large scale epidemiologic studies and investigator-initiated randomized trials of prevention and treatment of infectious diseases. His experience covers the full range of epidemiologic study designs including clinical trials, cohorts, case-control studies and mathematical modelling to study antibiotic resistance and infection prevention. Specific research interests include the epidemiology of antibiotic-resistant bacteria such as VRE, MRSA and MDR Enterobacteriaceae, selective decontamination in intensive care unit patients, prevention of ventilator-associated pneumonia, treatment of community-acquired pneumonia, and prevention and treatment of community-acquired pneumonia.
Since 2016 he is the Scientific Director of the research theme "Tackling Antimicrobial Resistance" of the Netherlands Centre for One Health (NCOH; www.ncoh.nl).
Since 2017 he is the chairman of the focus area Infection & Immunity at the UMC Utrecht, and board member of the Netherlands Antibiotic Development Platform (NADP; www.nadp.nl).
He acts as paid consultant for Janssen Vaccines (payments to UMC Utrecht) and Merck Sharp & Dohme B.V. (payments to UMC Utrecht).
He has received speakers fee from Takeda (Nov 2019).
He is a member of the Expertpanel of the Stichting Dierenautoriteit Nederland.
He is a member of the cluster Infectieziektenbestrijding from ZorgOnderzoek Nederland.
He is a member of the Scientific Advisory Board of GARDP (Global Antibiotic Research & Development Platform).
He is a member of the Independent Data Monitoring Committee of the PSK008 and PSK009 studies on pneumococcal conjugate vaccines from Sanofi Pasteur.
Fellowship and Awards
He has been (co-)applicant of a large number of national and international research grants. He is a VICI laureate (2006) from the Dutch Science Association, Principal Investigator of the CAPiTA study, coordinator of the EU-funded project R-GNOSIS, scientific coordinator of the IMI-funded consortiums COMBACTE-NET, COMBACTE-CARE and COMBACTE-MAGNET, and Work Package leader of the REMAP-CAP ICU study in PREPARE.
In 2015 he received the ESCMID 2015 Award for Excellence in Clinical Microbiology and Infectious Diseases.
In 2017 he received a honorary fellowship of the Royal College of Physicians of Ireland, and was awarded the ESCMID fellowship.
Research Output (706)
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19:The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial
Angus Derek C, Derde Lennie, Al-Beidh Farah, Annane Djillali, Arabi Yaseen, Beane Abigail, van Bentum-Puijk Wilma, Berry Lindsay, Bhimani Zahra, Bonten Marc, Bradbury Charlotte, Brunkhorst Frank, Buxton Meredith, Buzgau Adrian, Cheng Allen C, de Jong Menno, Detry Michelle, Estcourt Lise, Fitzgerald Mark, Goossens Herman, Green Cameron, Haniffa Rashan, Higgins Alisa M, Horvat Christopher, Hullegie Sebastiaan J, Kruger Peter, Lamontagne Francois, Lawler Patrick R, Linstrum Kelsey, Litton Edward, Lorenzi Elizabeth, Marshall John, McAuley Daniel, McGlothin Anna, McGuinness Shay, McVerry Bryan, Montgomery Stephanie, Mouncey Paul, Murthy Srinivas, Nichol Alistair, Parke Rachael, Parker Jane, Rowan Kathryn, Sanil Ashish, Santos Marlene, Saunders Christina, Seymour Christopher, Turner Anne, van de Veerdonk Frank, Venkatesh Balasubramanian, 2 sep 2020, In: JAMA - The Journal of The American Medical Association. 324 , p. 1317-1329 13 p.
Kretzschmar Mirjam E, Rozhnova Ganna, Bootsma Martin C J, van Boven Michiel, van de Wijgert Janneke H H M, Bonten Marc J M 16 jul 2020, In: The Lancet Public Health. 5 , p. e452-e459
Erratum:Correction to: Two Randomized Controlled Trials of Bacillus Calmette-Guérin Vaccination to reduce absenteeism among health care workers and hospital admission by elderly persons during the COVID-19 pandemic: A structured summary of the study protocols for two randomised controlled trials (Trials (2020) 21 1 (481))
Ten Doesschate Thijs, Moorlag Simone J C F M, van der Vaart Thomas W, Taks Esther, Debisarun Priya, Ten Oever Jaap, Bleeker-Rovers Chantal P, Verhagen Patricia Bruijning, Lalmohamed Arief, Ter Heine Rob, van Crevel Reinout, van de Wijgert Janneke, Janssen Axel B, Bonten Marc J, van Werkhoven Cornelis H, Netea Mihai G, 22 jun 2020, In: Trials. 21 , p. 555 1 p.
Mortality and host response aberrations associated with transient and persistent acute kidney injury in critically ill patients with sepsis:a prospective cohort study
Uhel Fabrice, Peters-Sengers Hessel, Falahi Fahimeh, Scicluna Brendon P, van Vught Lonneke A, Bonten Marc J, Cremer Olaf L, Schultz Marcus J, van der Poll Tom, 8 jun 2020, In: Intensive Care Medicine. 46 , p. 1576-1589 14 p.
Two Randomized Controlled Trials of Bacillus Calmette-Guerin Vaccination to reduce absenteeism among health care workers and hospital admission by elderly persons during the COVID-19 pandemic: A structured summary of the study protocols for two randomised controlled trials:A structured summary of the study protocols for two randomised controlled trials
Ten Doesschate Thijs, Moorlag Simone J C F M, van der Vaart Thomas W, Taks Esther, Debisarun Priya, Ten Oever Jaap, Bleeker-Rovers Chantal P, Verhagen Patricia Bruijning, Lalmohamed Arief, Ter Heine Rob, van Crevel Reinout, van de Wijgert Janneke, Janssen Axel B, Bonten Marc J, van Werkhoven Cornelis H, Netea Mihai G, 5 jun 2020, In: Trials. 21 2 p.
Netea Mihai G, Giamarellos-Bourboulis Evangelos J, Domínguez-Andrés Jorge, Curtis Nigel, van Crevel Reinout, van de Veerdonk Frank L, Bonten Marc 4 mei 2020, In: Cell. 181 , p. 969-977 9 p.
Impact of antimicrobial de-escalation on mortality: a literature review of study methodology and recommendations for observational studies
Van Heijl Inger, Schweitzer Valentijn A., van der Linden Paul D., Bonten Marc J. M., Van Werkhoven Cornelis H. 3 mei 2020, In: Expert review of Anti-infective Therapy. 18 , p. 405-413 9 p.
Bonten Marc J mei 2020, In: Critical care medicine. 48 , p. 736-738 3 p.
Contact isolation versus standard precautions to decrease acquisition of extended-spectrum β-lactamase-producing Enterobacterales in non-critical care wards:a cluster-randomised crossover trial
Maechler Friederike, Schwab Frank, Hansen Sonja, Fankhauser Carolina, Harbarth Stephan, Huttner Benedikt D., Diaz-Agero Cristina, Lopez Nieves, Canton Rafael, Ruiz-Garbajosa Patricia, Blok Hetty, Bonten Marc J., Kloosterman Fieke, Schotsman Joost, Cooper Ben S., Behnke Michael, Golembus Jennifer, Kola Axel, Gastmeier Petra mei 2020, In: The Lancet Infectious Diseases. 20 , p. 575-584 10 p.
Vincent Jean-Louis, Sakr Yasser, Singer Mervyn, Martin-Loeches Ignacio, Machado Flavia R, Marshall John C, Finfer Simon, Pelosi Paolo, Brazzi Luca, Aditianingsih Dita, Timsit Jean-François, Du Bin, Wittebole Xavier, Máca Jan, Kannan Santhana, Gorordo-Delsol Luis A, De Waele Jan J, Mehta Yatin, Bonten Marc J M, Khanna Ashish K, Kollef Marin, Human Mariesa, Angus Derek C, 24 mrt 2020, In: JAMA - The Journal of The American Medical Association. 323 , p. 1478-1487 10 p.